| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/13/2003 | US20030031704 Liposome composition for delivery of nucleic acid |
| 02/13/2003 | US20030031702 Teratogenic drug such as isotretinoin and a contraceptive packaged together with a label specifying avoidance of pregnancy while taking the teratogenic drug; unit dosage |
| 02/13/2003 | US20030031701 Forming a polymer solution/drug mixture of a polymer dissolved in an organic solvent and a suspended labile, removing the solvent and compressing |
| 02/13/2003 | US20030031700 Implanting biocompatible capsules containing a cellular source |
| 02/13/2003 | US20030031697 Crosslinkable macromers |
| 02/13/2003 | US20030031694 Controlled release particles |
| 02/13/2003 | US20030031660 Administering to the subject a therapeutically effective amount of heparanase for inducing bone formation |
| 02/13/2003 | US20030031659 For the treatment or prevention of a gastrointestinal infection caused by a pathogenic bacteria; for reducing insect and parasite populations in animal manure |
| 02/13/2003 | US20030031654 Prohormone convertase transformed cells and polypeptide synthesis |
| 02/13/2003 | US20030031631 Having surface tension, effective for therapy of respiratory systme disorders |
| 02/13/2003 | US20030029809 Apparatus for providing a red blood cell carrier |
| 02/13/2003 | US20030029444 Process for cooking/drying high-amylose starches |
| 02/13/2003 | US20030029086 Floral packaging material having great masters prints thereon |
| 02/13/2003 | CA2457100A1 Taste masking composition |
| 02/13/2003 | CA2455975A1 Mucin synthesis inhibitors |
| 02/13/2003 | CA2455858A1 Pharmaceutical preparations containing aminobenzene- sulfonic acid derivatives as the active ingredient |
| 02/13/2003 | CA2455852A1 Transdermal therapeutic system (reservoir-tts) for using pramipexole and ropinirole |
| 02/13/2003 | CA2455843A1 Therapeutic delivery compositions and methods of use thereof |
| 02/13/2003 | CA2455728A1 As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness |
| 02/13/2003 | CA2455598A1 Lipid constructs as therapeutic and imaging agents |
| 02/13/2003 | CA2455567A1 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same |
| 02/13/2003 | CA2455329A1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv |
| 02/13/2003 | CA2454918A1 Ophthalmic composition containing n-acetyl-cysteine for the treatment of dry-eye syndrome |
| 02/13/2003 | CA2454066A1 Pulmonary formulation |
| 02/13/2003 | CA2452529A1 Use of a blood-flow decrease preventing agent in conjunction with insufflating gas |
| 02/13/2003 | CA2451868A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 02/13/2003 | CA2451855A1 Oral pharmaceutical composition comprising an active principle capable of being subjected to high effect during its first passage through the intestine |
| 02/13/2003 | CA2450123A1 Biodegradable polyhydric alcohol esters |
| 02/12/2003 | EP1283060A1 Preparations for diagnosing infection with helicobacter pylori |
| 02/12/2003 | EP1283051A1 Stable insulin formulations |
| 02/12/2003 | EP1283045A1 Drug and food containing glucomannan for inhibiting IgE antibody |
| 02/12/2003 | EP1283044A2 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
| 02/12/2003 | EP1283043A1 Ophthalmic solution |
| 02/12/2003 | EP1283042A1 Aqueous liquid preparation |
| 02/12/2003 | EP1283041A1 Pharmaceutical compositions containing HIV-protease inhibitors |
| 02/12/2003 | EP1283040A1 Sustained release oral preparations |
| 02/12/2003 | EP1283036A1 Dry powder for inhalation |
| 02/12/2003 | EP1283035A2 Therapeutic preparation for inhalation containing parathyroid hormone |
| 02/12/2003 | EP1283034A2 Agglomerates of beta-lactam antibiotics |
| 02/12/2003 | EP1283031A2 Skin treatment composition |
| 02/12/2003 | EP1282690A1 Isolation of precursor cells and their use for tissue repair |
| 02/12/2003 | EP1282663A1 Gel comprised of a poly-$g(a)-1,4-glucan and starch |
| 02/12/2003 | EP1282592A2 Use of amines |
| 02/12/2003 | EP1282447A1 Stable polymeric micelle-type drug composition and method for the preparation thereof |
| 02/12/2003 | EP1282446A1 Pharmaceutical and/or cosmetic composition containing an organosiloxane and a phospholipid |
| 02/12/2003 | EP1282442A1 Cancer treatments by using a combination of an antibody against her2 and interleukin-2 |
| 02/12/2003 | EP1282436A2 Treatment of acute coronary syndrome with glp-1 |
| 02/12/2003 | EP1282434A1 Method for cell adhesion and wound healing |
| 02/12/2003 | EP1282430A2 Immune response modulation |
| 02/12/2003 | EP1282429A1 Pharmaceutical gel composition |
| 02/12/2003 | EP1282422A1 Ciprofloxacin infusion solutions with improved storage life |
| 02/12/2003 | EP1282416A2 Dehydroascorbic acid formulations and uses thereof |
| 02/12/2003 | EP1282409A1 Insulin formulation for inhalation |
| 02/12/2003 | EP1282408A1 Hydrogel composition for transdermal drug delivery |
| 02/12/2003 | EP1282407A1 Delivery mechanism for the introduction of biological substances to animals |
| 02/12/2003 | EP1282406A1 Pharmaceutical kit comprising midodrine as an active drug substance |
| 02/12/2003 | EP1282405A2 Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| 02/12/2003 | EP1282404A2 Method for preparing microparticles having a selected polymer molecular weight |
| 02/12/2003 | EP1282403A1 Non-invasive gene targeting to the brain |
| 02/12/2003 | EP1282402A1 Stabilized aqueous suspensions for parenteral use |
| 02/12/2003 | EP1282401A2 Stabilized steroidal suspension |
| 02/12/2003 | EP1282400A2 Pharmaceutical form of administration for peptides, methods for its production and use |
| 02/12/2003 | EP1282399A2 Rapidly disintegrating solid oral dosage form |
| 02/12/2003 | EP1282398A1 Inhalation therapy decongestant with foraminous carrier |
| 02/12/2003 | EP1282395A1 Use of ellagic acid as anti-pollution cosmetic agent |
| 02/12/2003 | EP1282387A1 Device for the coating of granulates and seeds |
| 02/12/2003 | EP1109534B1 Quick release pharmaceutical compositions of drug substances |
| 02/12/2003 | EP1003542B1 Use of substances having oxytocin activity for preparation of medicaments for wound healing |
| 02/12/2003 | EP0966299B1 Novel oral formulations of calcitonin |
| 02/12/2003 | EP0862456A4 Enzymatic method and compositions for treating intravitreal hemorrhagic blood |
| 02/12/2003 | EP0711154B1 Stabilized pharmaceutical composition containing bupropion |
| 02/12/2003 | EP0637246B1 Use of modified c-reactive protein for the preparation of a medicament for the treatment of cancer |
| 02/12/2003 | CN2535141Y Vacuum dring coating device |
| 02/12/2003 | CN1396830A Pharmaceutical parenteral composition containing biphosphonate |
| 02/12/2003 | CN1396828A Pharmaceutical composition comprising Pemetrexed together with monothioglycerol L-cystein or thioglycolic acid |
| 02/12/2003 | CN1396826A Use of pramipexole for treatment of addictive disorders |
| 02/12/2003 | CN1396824A Eye drops |
| 02/12/2003 | CN1396823A Electrospun pharmaceutical compositions |
| 02/12/2003 | CN1396822A Liposomes containing entrapped compound in supersaturated solution |
| 02/12/2003 | CN1395964A Medical usage of simonder wood oil |
| 02/12/2003 | CN1395961A Fatty emulsion of goldenrod for injection and its preparing process |
| 02/12/2003 | CN1395954A Chinese-medicinal plaster for treating inflammation and pain and its preparing process |
| 02/12/2003 | CN1395935A Citicoline sodium injection for intravenous injection and its preparing process |
| 02/12/2003 | CN1395928A Slow-releasing acipimox tablet |
| 02/12/2003 | CN1395927A Slow-releasing acipimox capsule |
| 02/12/2003 | CN1395925A Slow-releasing Anixitan tablet |
| 02/12/2003 | CN1395924A Slow-releasing Anixidan capsule |
| 02/12/2003 | CN1395922A Theopolyphenol composition for injection and its preparing process |
| 02/12/2003 | CN1395919A Quickly disintegrating and dissolving solid medicine composition for oral cavity and preparing process for its tablet |
| 02/12/2003 | CN1101425C Stable aqueous dispersions and stable water-dispersible dry xanthophyll powder, there production and use |
| 02/12/2003 | CN1101228C Treatment of conditions and disease |
| 02/12/2003 | CN1101224C Injection for giving up addiction |
| 02/12/2003 | CN1101217C Chinese patent medicine for curing diarrhea |
| 02/12/2003 | CN1101214C Extenal use disinfectant anagesic and production method thereof |
| 02/12/2003 | CN1101192C Compositions for topical treatment of erectile impotence |
| 02/12/2003 | CN1101191C Carbamazepine medicament with retarded active substance release |
| 02/12/2003 | CN1101187C Fluoxetine pharmaceutial formulations |
| 02/12/2003 | CN1101185C Release-controlling medicinal capsule able to form on-wall porous structure in body |
| 02/12/2003 | CN1101184C Process for preparing medical particles Qingkailing by wrapping chololic acid and animal extract with cyclodextrin |
| 02/12/2003 | CN1101183C Sustained release and implantation type mitomycin medicine and method for preparing same |